US WorldMeds
KY - Louisville
PharmaceuticalFocus: Specialty Pharmaceuticals
US WorldMeds is a life sciences company focused on Specialty Pharmaceuticals.
Neurology
Funding Stage
PUBLIC
Open Jobs
15
Pipeline & Clinical Trials
Non-conforming afamitresgene autoleucel
Synovial SarcomaClinical Trials (1)
NCT06617572Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
N/Alofexidine HCl
Renally Impaired SubjectsClinical Trials (1)
NCT02313103Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects
Phase 1Lofexidine HCl
Opioid DependenceClinical Trials (1)
NCT01650649Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Phase 1Lofexidine hydrochloride
Normal Healthy VolunteersClinical Trials (1)
NCT01629446Lofexidine Mass Balance in Volunteers
Phase 1Lofexidine
Normal Healthy VolunteersClinical Trials (1)
NCT04188730A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
Phase 1Lofexidine Hydrochloride
Liver FailureClinical Trials (1)
NCT02318836Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects
Phase 1Lofexidine HCl
Opioid DependenceClinical Trials (1)
NCT01558934Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Phase 1lofexidine administration in subjects seeking buprenorphine dose reduction
Substance Withdrawal SyndromeClinical Trials (1)
NCT02801357Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
Phase 1Lofexidine + Naltrexone
HealthyClinical Trials (1)
NCT02446002Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
Phase 1LUCEMYRA
Opioid Withdrawal (Disorder)Clinical Trials (1)
NCT06711640A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects
Phase 1Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
Endometrial CancerClinical Trials (1)
NCT04044859ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
Phase 1Lofexidine HCl
Opioid DependenceClinical Trials (1)
NCT01820442Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
Phase 1ADP adoptive cell therapy
NeoplasmsClinical Trials (1)
NCT03391778Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1Lofexidine
HealthyClinical Trials (1)
NCT02681198Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
Phase 1Lofexidine HCl
HealthyClinical Trials (1)
NCT01437306Lofexidine Food Effect Study in Healthy Volunteers
Phase 1Lofexidine hydrochloride
Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the ProductClinical Trials (1)
NCT01310296Lofexidine ADME & Mass Balance in Volunteers
Phase 1Afamitresgene autoleucel
Synovial SarcomaClinical Trials (1)
NCT05642455SPEARHEAD-3 Pediatric Study
Phase 1/2Lofexidine 0.18 MG
Opioid-use DisorderClinical Trials (1)
NCT04056182Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment
Phase 2Letetresgene autoleucel
NeoplasmsClinical Trials (1)
NCT03967223Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
Phase 2Botulinum Toxin Type B
DroolingClinical Trials (1)
NCT00515437A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Phase 2Letetresgene autoleucel
NeoplasmsClinical Trials (1)
NCT06703346Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Phase 2Lofexidine
Post Traumatic Stress Disorderafamitresgene autoleucel
Synovial SarcomaClinical Trials (1)
NCT04044768Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Phase 2Eflornithine
OsteosarcomaClinical Trials (1)
NCT07321912Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Phase 2Lofexidine
Opioid Withdrawal (Disorder)Clinical Trials (1)
NCT04070157Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
Phase 2Autologous genetically modified ADP-A2M4CD8 cells
Ovarian CancerClinical Trials (1)
NCT05601752ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
Phase 2Lofexidine
Opiate AddictionClinical Trials (1)
NCT00235729Lofexidine for Inpatient Opiate Detox
Phase 3Lofexidine HCl
Opioid DependenceClinical Trials (1)
NCT01863186Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
Phase 3Lofexidine
Opioid WithdrawalClinical Trials (1)
NCT02363998Open-Label, Safety Study of Lofexidine
Phase 3Lofexidine Oral Tablet
Opioid WithdrawalClinical Trials (1)
NCT04126083Lofexidine for Adults Undergoing Lumbar Spine Surgery
Phase 4Botulinum Toxin Type B
Cervical DystoniaClinical Trials (1)
NCT00702754An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia
Phase 4Open Jobs (15)
Financial Analyst
Remote
4h ago
Associate Director, Facilites
Philadelphia, PA, US
FT40 Full-TimeYesterday
$150K - $175K/yr
Facilities Engineer
Philadelphia, PA, US
FT40 Full-Time1w ago
Manager Inspection Readiness
Philadelphia, PA, US
1w ago
Scientific Strategy Lead
Business Development
1w ago
$200K - $240K/yr
Director, Field Medical Team
1w ago
$180K - $240K/yr
Regional Account Manager, Northeast
Field Based
Commercial2w ago
$160K - $195K/yr
Medical Science Advisor
1mo ago
$170K - $220K/yr
Manager, Quality Systems
Philadelphia, PA, US
FT40 Full-Time1mo ago
$120K - $137K/yr
Quality Assurance Specialist
Philadelphia, PA, US
Quality1mo ago
$40 - $52/yr
Medical Science Advisor
Field Based
1mo ago
$170K - $200K/yr
Computer System Quality Validation Engineer
Philadelphia, PA, US
FT40 Full-Time1mo ago
$108K - $132K/yr
Quality Validation Engineer
Philadelphia, PA, US
FT40 Full-Time1mo ago
$108K - $132K/yr
Sr Quality Assurance Specialist
Philadelphia, PA, US
Quality1mo ago
$40 - $52/yr
Quality Control Specialist
Philadelphia, PA, US
Manufacturing1mo ago
$40 - $52/yr
Interview Prep Quick Facts
Portfolio: 31 clinical trials
Top TAs: Gastroenterology, Nephrology, Oncology
Open Roles: 15 active jobs
Therapeutic Area Focus
Marketed
Pipeline
Hiring Trend
Actively Hiring
15
Open Roles
+17
Added
-2
Filled/Removed
Based on last 4 crawl cycles